Artelo Biosciences Inc [NASDAQ: ARTL] traded at a high on Monday, posting a 17.95 gain after which it closed the day’ session at $0.97.
The results of the trading session contributed to over 22828866 shares changing hands. Over the past one week, the price volatility of Artelo Biosciences Inc stands at 22.33% while the volatility over the past one month is 8.86%.
The market cap for ARTL stock reached $3.18 million, with 3.28 million shares outstanding and 3.25 million shares in the current float. Compared to the average trading volume of 24.02K shares, ARTL reached a trading volume of 22828866 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Artelo Biosciences Inc [ARTL]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ARTL shares is $5.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ARTL stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Artelo Biosciences Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 12, 2021.
The Average True Range (ATR) for Artelo Biosciences Inc is set at 0.10 The Price to Book ratio for the last quarter was 1.11, with the Price to Cash per share for the same quarter was set at 0.71.
How has ARTL stock performed recently?
Artelo Biosciences Inc [ARTL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.71. With this latest performance, ARTL shares gained by 0.98% in over the last four-week period, additionally sinking by -11.06% over the last 6 months – not to mention a drop of -38.61% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ARTL stock in for the last two-week period is set at 52.42, with the RSI for the last a single of trading hit 57.47, and the three-weeks RSI is set at 49.56 for Artelo Biosciences Inc [ARTL]. The present Moving Average for the last 50 days of trading for this stock 1.0515, while it was recorded at 0.8787 for the last single week of trading, and 1.1563 for the last 200 days.
Artelo Biosciences Inc [ARTL]: Deeper insight into the fundamentals
Artelo Biosciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.44 and a Current Ratio set at 1.44.
Earnings analysis for Artelo Biosciences Inc [ARTL]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ARTL. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Artelo Biosciences Inc go to 48.77%.
Insider trade positions for Artelo Biosciences Inc [ARTL]
There are presently around $1.05%, or 1.06%% of ARTL stock, in the hands of institutional investors.
